A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

NCT01033487 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive
Lung Diseases
Respiratory Tract Diseases
Chronic Obstructive Airway Disease
COPD

Interventions

DRUG: placebo
DRUG: active comparator
DRUG: Low Dose PF-03635659
DRUG: Mid Dose PF-03635659
DRUG: High Dose PF-03635659

Sponsor

Pfizer